|
|
Line 319: |
Line 319: |
|
| |
|
| =Studies - Not Catagorized= | | =Studies - Not Catagorized= |
|
| |
| ===2021: [https://onlinelibrary.wiley.com/doi/10.1111/add.15628?fbclid=IwAR1Dliz9fOj83wYQ3muEXwsV_ZdVvi0d-ggBaJStLJqVl0Va3dpHfwt0Twg E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: Randomised controlled trial]===
| |
| *Participants previously unable to stop smoking with conventional treatments.
| |
| *Validated smoking reduction (including cessation) was achieved by 26.5% vs 6.0% of participants in the EC and NRT study arms, respectively. Sustained validated abstinence rates at 6 months were 19.1% vs 3.0%.
| |
| *[https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.15628 PDF Version]
| |
| *Citation: Myers Smith, K., Phillips-Waller, A., Pesola, F., McRobbie, H., Przulj, D., Orzol, M., and Hajek, P. (2021) E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: Randomised controlled trial. Addiction, doi.org/10.1111/add.15628
| |
| *Acknowledgements: The study was funded by a Tobacco Advisory Group project grant, Cancer Research UK (C6815/A20503).
| |
|
| |
|
| |
|
| ===2021: [https://pubmed.ncbi.nlm.nih.gov/33798919/ A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation]=== | | ===2021: [https://pubmed.ncbi.nlm.nih.gov/33798919/ A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation]=== |